Tony Casciano
Chief Commercial Officer (CCO) @Viridian Therapeutics, Inc.
Signup · Get unlimited contacts
WORK HISTORY
Chief Commercial Officer (CCO) @Viridian Therapeutics, Inc.
Waltham, MA, US
Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian\'s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED)
SKILLS
ABOUT TONY CASCIANO
Tony is a senior biopharmaceutical executive with proven success building and leading high-performing teams through multiple product launches and business turnarounds in both large and small companies. He has delivered strong results across multiple therapeutic areas and business models. He has worked in heavily matrixed, multi-national organizations including Sanofi and Genzyme and has extensive US commercial experience with recent successful launches of specialized drugs across Hematology/Oncology, Maternal (orphan disease) and Women’s Health.Specialties: Ophthalmology, Hematology/Oncology, Cardiology, Neurology, Orthopedics, Maternal Health, large and small molecules, specialty and retail drugs, buy-and bill, orphan and rare diseases, P&L management, organizational design, governance, portfolio prioritization, in & out-licensing, business development, strategic planning, cross-functional leadership, sales, marketing, market access, and commercial operations.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.